Clinical Trial Update: Tissue-resident Immune Cell Subsets in aGVHD

View source ↗

Summary

A clinical trial from Nanfang Hospital/Southern Medical University is investigating tissue-resident immune cell subsets in acute graft-versus-host disease and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Graft-versus-Host Disease, Hematopoietic Stem Cell Transplantation | Status: RECRUITING